Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension

Hypertension

Volumn 61, Issue 6, 2013, Pages 1309-1315

  Tryambake, Dinesh ^a,b   He, Jiabao ^a   Firbank, Michael J ^a,b   O'Brien, John T ^a   Blamire, Andrew M ^a,b   Ford, Gary A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

aging; blood flow; blood pressure; cardiovascular disease; MRI

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GRAY MATTER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGING; BLOOD FLOW; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; MRI;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BRAIN; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; REGIONAL BLOOD FLOW; TREATMENT OUTCOME;

EID: 84878909009     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.200972     Document Type: Article

References (36)

1. Black HR. The burden of cardiovascular disease: following the link from hypertension to myocardial infarction and heart failure. Am J Hypertens. 2003; 16(9 pt 2): 4S-6S. (Pubitemid 37175978)
2. Kashgarian M. Pathology of small blood vessel disease in hypertension. Am J Kidney Dis. 1985; 5: A104-A110. (Pubitemid 15111808)
3. Tang JP, Xu ZQ, Douglas FL, Rakhit A, Melethil S. Increased blood-brain barrier permeability of amino acids in chronic hypertension. Life Sci. 1993; 53: PL417-PL420. (Pubitemid 223040727)
4. Cohen RA. Hypertension and cerebral blood flow: implications for the development of vascular cognitive impairment in the elderly. Stroke. 2007; 38: 1715-1717. (Pubitemid 46847219)
5. Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: A prospective population-based study. J Hum Hypertens. 1995; 9: 175-180.
6. Wysocki M, Luo X, Schmeidler J, Dahlman K, Lesser GT, Grossman H, Haroutunian V, Beeri MS. Hypertension is associated with cognitive decline in elderly people at high risk for dementia. Am J Geriatr Psychiatry. 2012; 20: 179-187.
7. Igase M, Kohara K, Miki T. The Association between Hypertension and Dementia in the Elderly. Int J Hypertens. 2012; 2012: 320648.
8. Chalmers J, Arima H. Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials. Pol Arch Med Wewn. 2009; 119: 373-380.
9. Lipsitz LA, Gagnon M, Vyas M, Iloputaife I, Kiely DK, Sorond F, Serrador J, Cheng DM, Babikian V, Cupples LA. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005; 45: 216-221. (Pubitemid 40179963)
10. Nobili F, Rodriguez G, Marenco S, De Carli F, Gambaro M, Castello C, Pontremoli R, Rosadini G. Regional cerebral blood flow in chronic hypertension. A correlative study. Stroke. 1993; 24: 1148-1153. (Pubitemid 23237551)
11. Lipsitz LA, Mukai S, Hamner J, Gagnon M, Babikian V. Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke. 2000; 31: 1897-1903. (Pubitemid 30620470)
12. McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database of Systematic Reviews. 2009: CD004034.
13. Forette F, Seux ML, Staessen JA, et al.; Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002; 162: 2046-2052. (Pubitemid 35168212)
14. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C; HYVET Investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial. Lancet Neurol. 2008; 7: 683-689.
15. Graham DI. Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension. Br Med J. 1975; 4: 739.
16. Goldstein S, Reivich M. Cerebral blood flow and metabolism in aging and dementia. Clin Neuropharmacol. 1991; 14(suppl 1): S34-S44.
17. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, O'Brien JT. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology. 2011; 76: 1478-1484.
18. Colloby SJ, Firbank MJ, He J, Thomas AJ, Vasudev A, Parry SW, O'Brien JT. Regional cerebral blood flow in late-life depression: Arterial spin labelling magnetic resonance study. Br J Psychiatry. 2012; 200: 150-155.
19. Waldstein SR, Lefkowitz DM, Siegel EL, Rosenberger WF, Spencer RJ, Tankard CF, Manukyan Z, Gerber EJ, Katzel L. Reduced cerebral blood flow in older men with higher levels of blood pressure. J Hypertens. 2010; 28: 993-998.
20. Watanabe M, Hirano T, Okamoto S, Shiraishi S, Tomiguchi S, Uchino M. Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study. Hypertens Res. 2010; 33: 43-48.
21. He J, Blamire AM. Application of variable-rate selective excitation pulses for spin labeling in perfusion MRI. Magn Reson Med. 2010; 63: 842-847. National Institute of Clinical Excellence
22. Kim SG. Quantification of relative cerebral blood flow change by flowsensitive alternating inversion recovery (FAIR) technique: Application to functional mapping. Magn Reson Med. 1995; 34: 293-301.
23. Kim SG, Tsekos NV. Perfusion imaging by a flow-sensitive alternating inversion recovery (FAIR) technique: Application to functional brain imaging. Magn Reson Med. 1997; 37: 425-435. (Pubitemid 27107969)
24. Clare S, Jezzard P. Rapid T(1) mapping using multislice echo planar imaging. Magn Reson Med. 2001; 45: 630-634. (Pubitemid 32260085)
25. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr. 1998; 22: 139-152.
26. Frackowiak RSJ. Human Brain Function. Boston: Elsevier Academic Press; 2004.
27. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994; 18: 192-205. (Pubitemid 24100002)
28. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002; 15: 273-289. (Pubitemid 34852226)
29. Francis ST, Gowland PA, Bowtell RW. Continuous saturation EPI with diffusion weighting at 3.0 T. NMR Biomed. 1999; 12: 440-450. (Pubitemid 30017000)
30. Frackowiak RS, Lenzi GL, Jones T, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr. 1980; 4: 727-736. (Pubitemid 11247403)
31. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke. 2007; 38: 1766-1773. (Pubitemid 46850653)
32. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke. 2008; 39: 349-354. (Pubitemid 351619454)
33. Waldemar G, Ibsen H, Strandgaard S, Andersen AR, Rasmussen S, Paulson OB. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension. Am J Hypertens. 1990; 3(6 pt 1): 464-470. (Pubitemid 20380195)
34. Kimura Y, Kitagawa K, Oku N, Kajimoto K, Kato H, Tanaka M, Sakaguchi M, Hougaku H, Sakoda S, Hatazawa J. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions. Hypertens Res. 2008; 31: 2147-2154.
35. Pandita-Gunawardena ND, Clarke SE. Amlodipine lowers blood pressure without affecting cerebral blood flow as measured by single photon emission computed tomography in elderly hypertensive subjects. Age Ageing. 1999; 28: 451-457. (Pubitemid 29438515)
36. Lassen NA. Autoregulation of cerebral blood flow. Circ Res. 1964; 15(suppl): 201-204.